Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
new york blog main
6
×
boston blog main
boston top stories
national top stories
clinical trials
new york top stories
boston
fda
startups
amgen
biogen
cancer
deals
europe blog main
national
novartis
ptc therapeutics
san francisco blog main
san francisco top stories
vc
venture capital
abbvie
accent therapeutics
aducanumab
alirocumab
allergan
alnylam pharmaceuticals
alzheimer's disease
amblyotech
antisense oligonucleotide
asklepios biopharmaceutical
azacitidine
benzodiazepines
beta-thalassemia
bioeurope
biohaven
biomarin pharmaceutical
What
medicines
6
×
new
6
×
fda
aims
based
brings
class
developing
drugs
ipo
research
acquire
activity
adults
agreed
allergan
approach
approvals
approved
backed
begin
billion
bio
biogen
biosciences
biotech
bio’s
bubbles
called
cash
cause
cells
ceo
cholesterol
clamped
clinical
codiak
company
compound
covid
Language
unset
6
×
Current search:
unset
×
new
×
medicines
×
" new york blog main "
×
@xconomy.com
3 years ago
Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
